293
Views
19
CrossRef citations to date
0
Altmetric
EPIDEMIOLOGY

Clinical varieties and epidemiological aspects of amyotrophic lateral sclerosis in the Caribbean island of Guadeloupe: A new focus of ALS associated with Parkinsonism

, , , , , & show all
Pages 216-223 | Received 29 Aug 2014, Accepted 22 Nov 2014, Published online: 03 Feb 2015

References

  • Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81: 385–90.
  • Factor-Litvak P, Al-Chalabi A, Ascherio A, Bradley W, Chío A, Garruto R, et al. Current pathways for epidemiological research in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14 (Suppl 1): 33–43.
  • Fong KY, Yu YL, Chan YW, Kay R, Chan J, Yang Z, et al. Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture. Neuroepidemiology. 1996;15:239–45.
  • Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007; 68:1002–7.
  • Okamoto K, Kobashi G, Washio M, Sasaki S, Yokoyama T, Miyake Y, et al. Descriptive epidemiology of amyotrophic lateral sclerosis in Japan, 1995–2001. J Epidemiol. 2005; 15:20–3.
  • Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population based mortality study. Neurology. 2009;72:1640–5.
  • Ravits J, Laurie P, Fan Y, Moore D H. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss post mortem. Neurology. 2007;68:1576–82.
  • Ravits J, Appel S, Baloh RH, Barohn R, Brooks BR, Elman L, et al. Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14 (Suppl 1):5–18.
  • Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998; 51:1546–54.
  • Kiernan JA, Hudson AJ. Frontal lobe atrophy in motor neuron diseases. Brain. 1994;117: 747–57.
  • Abe K, Fujimura H, Toyooka K, Sakoda S, Yorifuji S, Yanagihara T. Cognitive function in amyotrophic lateral sclerosis. J Neurol Sci. 1997;148:95–100 .
  • Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology. 2002;59:1077–9 .
  • Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B.Are amyotrophic lateral sclerosis patients cognitively normal? Neurology. 2003;60:1094–7.
  • Benajiba L, Le Ber I, Camuzat A, Lacoste M, Thomas- Anterion C, Couratier P, et al. Frontotemporal Lobar Degeneration with Motoneuron Disease: TARDBP mutations in motor neuron disease with frontotemporal lobar degeneration. Ann Neurol. 2009;65:470–3.
  • Chen-Plotkin AS, Martinez-Lage M, Sleiman PM, Hu W, Greene R, Wood EM, et al. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol. 2011;68:488–97.
  • Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2012;83:102–8.
  • Kurland LT, Mulder DW. Epidemiologic investigations of amyotrophic lateral sclerosis. 1. Preliminary report on geographic distribution, with special reference to the Mariana Islands, including clinical and pathological observations. Neurology. 1954;4:355–78, 438–48.
  • Kokubo Y, Kuzuhara S, Narita Y. Geographical distribution of amyotrophic lateral sclerosis with neurofibrillary tangles in the Kii Peninsula of Japan. J Neurol. 2000;247:850–2.
  • Plato CC, Galasko D, Garruto RM, Plato M, Gamst A, Craig UK, et al. ALS and PDC of Guam. Forty-year follow-up. Neurology. 2002;58:765–73.
  • Gilbert RM, Fahn S, Mitsumoto H, Rowland LP. Parkinsonism and motor neuron diseases: 27 patients with diverse overlap syndromes. Mov Disord. 2010;25:1868–75.
  • Rusina R, Kovacs GG, Fiala J, Hort J, Ridzoň P, Holmerová I, et al. FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three cases. BMC Neurol. 2011;11:50.
  • Caparros-Lefebvre D, Elbaz A. Possible relation of atypical Parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group. Lancet. 1999;354:281–6.
  • Caparros-Lefebvre D, Sergeant N, Lees A, Camuzat A, Daniel S, Lannuzel A, et al. Guadeloupean Parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. Brain. 2002;125:801–11.
  • Lannuzel A, Höglinger GU, Verhaeghe S, Gire L, Belson S, Escobar-Khondiker M, et al. Atypical Parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? Brain. 2007;130:816–27.
  • Lannuzel A, Michel PP, Höglinger G, Champy P, Jousset A, Medja F, et al. The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic neurons by impairment of energy metabolism. Neuroscience. 2003;121:287–96.
  • Champy P, Melot A, Guérineau V, Gleye C, Fall D, Höglinger G, et al. Quantification of acetogenins in Annona muricata linked to atypical Parkinsonism in Guadeloupe. Movement Disorders. 2005;20:1629–33.
  • Escobar-Khondiker M, Höllerhage M, Muriel MP, Champy P, Bach A, Depienne C, et al. Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons. The Journal of Neuroscience. 2007;27: 7827–37.
  • Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
  • Liu MS, Cui LY, Fan DS; Chinese ALS Association. Age at onset of amyotrophic lateral sclerosis in China. Acta Neurol Scand. 2014;129:163–7.
  • Kihira T, Yoshida S, Murata K, Ishiguti H, Kondo T, Kohmoto J, et al. Changes in the incidence and clinical features of ALS in the Koza, Kozagawa, and Kushimoto area of the Kii Peninsula: from the 1960s to the 2000s (follow-up study). Brain Nerve. 2010;62:72–80.
  • Cox PA, Banack SA, Murch SJ. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc Natl Acad Sci U S A. 2003;100:13380–3.
  • Plato CC, Garruto RM, Galasko D, Craig UK, Plato M, Gamst A, et al. Amyotrophic lateral sclerosis and Parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol. 2003;157: 149–57.
  • Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, et al. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2008;79:33–7.
  • Spencer PS, Nunn PB, Hugon J, Ludolph AC, Ross SM, Roy DN, et al. Guam amyotrophic lateral sclerosis- Parkinsonism-dementia linked to a plant excitant neurotoxin. Science. 1987;237:517–22.
  • Ishiura H, Takahashi Y, Mitsui J, Yoshida S, Kihira T, Kokubo Y, et al. C9orf72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan. Arch Neurol. 2012;69:1154–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.